Lloyd P Haskell
6PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 27, 2026
Low-Dose Rivaroxaban Plus Aspirin in Patients With PAD Undergoing Lower Extremity Revascularization With and Without History of Prior Limb Revascularization: Insight From the VOYAGER-PAD Trial.Mario Enrico Canonico, Jessica Parr, E Sebastian Debus
|Oct 23, 2025
Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD.Shea Hogan, Michael Szarek, E Sebastian Debus
|Apr 02, 2024
Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial.Zhong Yuan, Bennett Levitan, Hsiaowei Deng
|Feb 16, 2022
Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone.Scott D Berkowitz, Rupert M Bauersachs, Michael Szarek
Pageof 1
Frequent Collaborators
6 joint publications
Rupert M Bauersachs
6 joint publications
Scott E Berkowitz
6 joint publications
Marc P Bonaca
5 joint publications
Eva Muehlhofer
5 joint publications
Manesh R Patel
5 joint publications
Sonia S Anand
4 joint publications
Michael Szarek
4 joint publications
Eike Sebastian Debus
3 joint publications
Connie N Hess
2 joint publications
Mark R Nehler
